Loading...
Chemical structure of Cancer-Targeting Compound 1

GC33138

Cancer-Targeting Compound 1

Also known as 4-[2-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile

Cancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2

ChemicalCAS1007581-62-5MW299.35FormulaC15H13N3O2S
CAS number
1007581-62-5
Molecular weight
299.35
Formula
C15H13N3O2S
Solubility
Soluble in DMSO
InChIKey
OLHKCEIOFAUDPT-UHFFFAOYSA-N
Catalogue number
GC33138
Brand
GLPBIO
Computed properties PubChem CID 24738462 · XLogP 2.8 · TPSA 94.5 Ų · H-bond donors 0
XLogP
2.8
TPSA
94.5 Ų
H-bond donors
0
H-bond acceptors
5
Rotatable bonds
2
Heavy atoms
21

SMILES CC1(COC(=O)N1C2=NC(=CS2)C3=CC=C(C=C3)C#N)C

Computed descriptors from PubChem (CID 24738462), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.